Quantum Leap Energy LLC plans to utilize technology acquired from One 30 Seven to develop Creber Units to process water-soluble nuclear waste by accelerating beta decay of radioactive waste, such as Cesium-137 and Strontium-90.There are currently 390,000 Metric Tons of radioactive waste globally, of which over 90,000 Metric Tons sit in the United States. [1]The total estimated liability for the Department of Energy failing to dispose of commercial spent fuel was estimated at $44.5 billion in 2024, not inclu ...

U.S. stock futures were higher this morning, with the Dow futures falling more than 150 points on Wednesday.Shares of Karooooo Ltd (NASDAQ:KARO) fell sharply in pre-market trading following downbeat second-quarter earnings.Karooooo reported quarterly earnings of 44 cents per share which missed the analyst consensus estimate of 46 cents per share. The company reported quarterly sales of $75.598 million which beat the analyst consensus estimate of $75.510 million.Karooooo shares dipped 9.3% to $51.15 in pre-m ...

Core Viewpoint - ASP Isotopes Inc. has announced a public offering of 17,167,380 shares of its common stock, aiming to raise approximately $210.3 million before expenses, with the offering expected to close on October 16, 2025 [1][4]. Group 1: Offering Details - The company has granted underwriters a 30-day option to purchase approximately $31.5 million of additional shares at the offering price [2]. - The last sale price of the shares on October 14, 2025, was reported at $14.05 per share [3]. - The offering is made under a shelf registration statement filed with the SEC on October 14, 2025, which became effective upon filing [5]. Group 2: Use of Proceeds - The net proceeds from the offering will be used for general corporate purposes, including working capital, operating expenses, and capital expenditures [4]. Group 3: Company Overview - ASP Isotopes Inc. is focused on developing technology and processes for isotope production, particularly for healthcare and technology industries, utilizing proprietary Aerodynamic Separation Process technology [7]. - The company plans to enrich isotopes for the nuclear energy sector using Quantum Enrichment technology [7]. - There is a growing demand for various isotopes, including Silicon-28 for quantum computing and Molybdenum isotopes for healthcare applications, indicating a robust market potential for the company's offerings [8].

WASHINGTON, Oct. 14, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes” or the “Company”), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today announced that it is commencing an underwritten public offering of shares of its common stock. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual ...

WASHINGTON, Oct. 13, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes” or the “Company”), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today provided a business development update, including a supply agreement for the largest quantity of enriched silicon-28 received by the Company to date and a strategic acquisition of a radiopharmacy in the United States to complement and expand th ...

*** Limited places remain available for institutional investors for this previously announced Investor Access Event *** WASHINGTON, Oct. 10, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes” or the “Company”), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today announced that it will host an Institutional Investor Access Event in South Africa from November 11-13, 2025. **There is als ...

Core Insights - ASP Isotopes Inc. has received a purchase order for enriched Barium-137 from a U.S.-based customer, with delivery scheduled for Q1 2026 [1] - Enriched Barium-137 is becoming essential for ion-trap quantum computing, facilitating the development of large-scale quantum machines [2][5] - The material's stable qubit platform enhances the reliability of quantum processors, crucial for scaling from small systems to fault-tolerant quantum computers [3] Company Overview - ASP Isotopes Inc. focuses on developing technology and processes for isotope production across multiple industries, employing proprietary Aerodynamic Separation Process technology [8] - The company aims to produce highly enriched isotopes for healthcare and technology sectors, with plans to enrich isotopes for the nuclear energy sector using Quantum Enrichment technology [8][9] - ASP Isotopes is positioned to meet the growing demand for isotopes like Silicon-28 and Molybdenum-100, which are critical for emerging applications in quantum computing and healthcare [9] Market Dynamics - The demand for enriched Barium-137 is expected to rise as industries seek commercially viable quantum computing solutions [5] - The isotopes market is evolving rapidly, with applications spanning quantum computing, semiconductors, AI, and data center construction [7] - ASP Isotopes aims to establish itself as a leading supplier in this dynamic market, supporting breakthrough technologies that will shape the future [6][7]

Core Points - ASP Isotopes Inc. has appointed Robert Ainscow as Interim CEO while Paul Mann takes a temporary leave of absence for health reasons [1][3] - Michael Cunniffe has been appointed as CFO of Quantum Leap Energy LLC, effective October 1, 2025 [6][7] Company Leadership Changes - Paul Mann will transition to the role of Executive Chairman, focusing on overall leadership and strategic direction [2] - Robert Ainscow, co-founder and current COO, will manage CEO responsibilities and maintain key industry relationships during Mann's recovery [5][4] Health Update - Paul Mann underwent successful orthopedic surgery on September 19, 2025, but his recovery may take several months [3] Upcoming Investor Events - ASP Isotopes will host an Institutional Investor Access Event in South Africa on November 12 and 13, 2025 [9] - The company plans to provide quarterly business updates starting in November 2025 [11] Company Overview - ASP Isotopes Inc. focuses on developing technology for isotope production, particularly for healthcare and technology industries [12] - The company employs proprietary Aerodynamic Separation Process technology and has facilities in Pretoria, South Africa [12][13]

Core Insights - ASP Isotopes Inc. has appointed Ralph L. Hunter, Jr. to its board of directors, enhancing its leadership in the nuclear energy sector [1][4] - Hunter brings over thirty years of experience in the nuclear power industry, with expertise in nuclear technology development and commercialization [2][3] - The company focuses on producing isotopes for various industries, including healthcare and nuclear energy, utilizing its proprietary Aerodynamic Separation Process [5][6] Company Overview - ASP Isotopes Inc. is dedicated to developing technology and processes for isotope production across multiple industries [5] - The company employs proprietary technology for isotope enrichment, with initial focus on highly enriched isotopes for healthcare and technology [5] - Plans include enriching isotopes for the nuclear energy sector, addressing the growing demand for isotopes in emerging applications [6] Leadership and Expertise - Ralph L. Hunter, Jr. has held significant leadership roles, including Chairman and CEO of RC Nuclear Consultants and President and CEO of Orion Nuclear Energy Corporation [2][3] - His experience includes promoting U.S. nuclear energy exports and serving on the board of Rolls-Royce SMR Limited, contributing to the UK's clean energy initiatives [2] - Hunter's appointment is expected to assist ASP Isotopes in navigating the complex nuclear regulatory environment and advancing its technologies [4]

Core Insights - The individual has retired after over 43 years in investment research, now operating independently to provide actionable investment insights [1] - The focus is on rules and factor-based equity investing strategies, emphasizing the use of numbers to inspire human intelligence-driven investment narratives [1] - A unique approach combines quantitative analysis with classic fundamental analysis to uncover the true story of companies and their stocks [1] Investment Strategy - The individual has extensive experience covering a wide range of stocks, including large cap, small cap, micro cap, value, growth, and special situations [1] - Previous roles included managing a high-yield fixed-income fund and conducting research on quantitative asset allocation strategies, foundational to modern Robo Advising [1] - The individual has authored two books on stock selection and analysis, showcasing a commitment to investor education [1] Future Outlook - The individual expresses enthusiasm for the new role on Seeking Alpha, inviting feedback and criticism from the audience [1]